Braveheart Investment Group (AIM: BRH), is pleased to provide an update concerning progress with proof of concept for a COVID-19 test that Paraytec Limited is conducting with the University of Sheffield.
The Proof of Concept trials are focused on two separate elements of the test, the Optical Detection System, and Capture & Signal Generation Modules, both of which are required to be achieved for the trial to be successful.
Proof of Concept has been achieved for the Optical Detection System and development work continues to optimise detection sensitivity. Minor logistical issues arising from increased regional COVID-19 restrictions has meant that final proof of concept trials continue for the Capture & Signal Generation Modules and the results are now anticipated on 16 October 2020.
For further information:
Braveheart Investment Group plc
Tel: 01738 587555
Viv Hallam, Executive Director
Allenby Capital Limited (Nominated Adviser and Joint Broker)
Tel: 020 3328 5656
David Worlidge / James Hornigold
Peterhouse Capital Limited (Joint Broker)
Tel: 020 7469 0936
Heena Karani / Lucy Williams
If anyone reads this article found it useful, helpful? Then please subscribe www.share-talk.com or follow SHARE TALK on our Twitter page for future updates.
Terms of Website Use
All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned